BRIDION 500 mg/5 ml sol inj 500 mg 10 pce

7680585090028 CH-58509 V03AB35 15.01.0.
BRIDION 500 mg/5 ml sol inj 500 mg 10 pce
BRIDION 500 mg/5 ml sol inj 500 mg 10 pce
BRIDION 500 mg/5 ml sol inj 500 mg 10 pce
1 / 3
google

Details

Product number
5850902
CPT
-
Packaging group
10
Unit
Ampulle(n)
Composition
sugammadexum 500 mg ut sugammadexum natricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 48.5 mg.

Articles (1)

Bridion 500 mg/5 ml, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/07/2026
Professional SmPC
Français
15/07/2026
Professional SmPC
Italien
15/07/2026

Detailed composition

Substance Quantity Type Category
sugammadexum
500.0 MG Substance Wirkstoff (Principe actif)
sugammadexum natricum
- Substance WIZUS
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
48.5 MG Substance HBESI

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
58509
Drug name
Bridion 100 mg/ml, Injektionslösung
Galenic form
LSPA
ATC Code
V03AB35
Authorization status
Z
Dispensation category
B
First authorization
07/01/2010
Authorization expiration date
31/12/9999
IT number
15.01.0.
Domain
Human medicine
Field of application
Aufhebung der durch Recuronium oder Vecuronium induzierten neuromuskulären Blockade

Packaging details

Description (FR)
BRIDION 500 mg/5 ml sol inj 500 mg 10 pce
Description (DE)
BRIDION 500 mg/5 ml Inj Lös 500 mg 10 Stk
Market launch
07/01/2010
Narcotic (BTM)
No

Other packaging sizes

BRIDION 200 mg/2 ml sol inj 200 mg 10 pce
10 AMP
View
Buy us a coffee Explore the data